Diagnostic Refinement and Educational Approaches in Managing Bone Marrow Transplantation

Description

This randomized, phase I/II, open-label study will investigate the efficacy and safety of an educational sleep intervention vs standard of care in adults undergoing alloHSCT. The randomization target in this pilot phase is 60 patients.

Conditions

GVHD, Bone Marrow Transplant Complications

Study Overview

Study Details

Study overview

This randomized, phase I/II, open-label study will investigate the efficacy and safety of an educational sleep intervention vs standard of care in adults undergoing alloHSCT. The randomization target in this pilot phase is 60 patients.

Diagnostic Refinement and Educational Approaches in Managing Bone Marrow Transplantation (DREAM-BMT)

Diagnostic Refinement and Educational Approaches in Managing Bone Marrow Transplantation

Condition
GVHD
Intervention / Treatment

-

Contacts and Locations

San Diego

Scripps Health, San Diego, California, United States, 92037

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Male or female patients aged 18 or older at the time of study informed consent.
  • * Have plan to undergo alloHSCT from any donor source using bone marrow, peripheral blood stem cells, or cord blood. Recipients of non-myeloablative, myeloablative and reduced intensity conditioning are eligible.
  • * Patients have access to digital device capable of downloading study app
  • * Patients able to read study documents and able to complete informed consent within the study app
  • * Failed prior alloHSCT within the past 6 months

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Scripps Translational Science Institute,

Study Record Dates

2026-10-01